To provide some context as to why it may be taking so long for the trial results to be analyzed and reported, consider the resources CytoDyn currently has at their disposal. We're talking about a handful of employees here folks, with multiple trials in progress! As a result, they're outsourcing just about everything, making their trial timelines heavily dependent on third-parties.

Contrast that to how a major pharma operates. Each clinical trial is assigned a medical director, a team of researchers, bio-statisticians, laboratory staff, analysts, admin staff, and anything else overhead can afford all internal to the company. Then there are executive medical directors overseeing the medical directors and a VP of clinical trial development on top of that and we're not even into the highest levels of management. They have a legal team, a financial team - not just one person handling each. And they have revenues.

All this means to me is we must be as patient as Warren Buffet. Good times are coming.